Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of Family Clinic and Municipality (FACAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03659721
Recruitment Status : Active, not recruiting
First Posted : September 6, 2018
Last Update Posted : January 25, 2022
Sponsor:
Collaborators:
Odense University Hospital
Syddansk Universitet
Odense Patient Data Explorative Network
Odense Kommune
Information provided by (Responsible Party):
VIVE - The Danish Center for Social Science Research

Brief Summary:
This trial is a randomized controlled trial with the aim is to assess the effectiveness of Family Clinic and Municipality (FACAM) to improve mother-child relationship, maternal health, maternal mental health, and the development and well-being of the child.

Condition or disease Intervention/treatment Phase
At-risk Pregnant Women Behavioral: FACAM Behavioral: Care as Usual Behavioral: COS-P Not Applicable

Detailed Description:

Pregnant women who struggle with psychosocial challenges during pregnancy have a higher risk of preterm birth, giving birth to a child with low birth weight and a higher risk of complications during pregnancy both for mother and child. An early and coordinated intervention to reduce inequality in health may be important for this group of vulnerable women.

The FACAM intervention is developed in Odense with the aim of reducing inequality in health by giving vulnerable pregnant women and their children the best possible start in life by offering an interdisciplinary coordinated support. The support will be offered by Odense municipality, the family clinic (Familieambulatoriet), and local voluntary organizations.

The aim of the trial is to assess the effectiveness of FACAM to improve mother-child relationship, maternal health, maternal mental health, and the development and well-being of the child.

The study is a Randomized Controlled Trial (RCT). A total of 320 pregnant women will be randomized to FACAM or Care as Usual.

Participants are pregnant women categorized as antenatal care group 3 or 4, living in Odense and with a referral to Familieambulatoriet, OUH. Participants must be able to fill out questionnaires in Danish or English.

Data will be collected at baseline (pregnancy), and when the child is 3 and 12 months old.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 332 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: The study is a prospective randomized controlled trial with two study arms: intervention (FACAM) and care as usual (CAU). Pregnant women are randomized to receive either FACAM or CAU.
Masking: Double (Investigator, Outcomes Assessor)
Masking Description: As the participants are offered extra support as the intervention neither participants nor care providers can be blinded. Outcome assessor and data analyst will be blinded.
Primary Purpose: Prevention
Official Title: The Effects of Family Clinic and Municipality (FACAM)
Actual Study Start Date : October 1, 2018
Estimated Primary Completion Date : March 31, 2023
Estimated Study Completion Date : March 31, 2023

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Family Issues

Arm Intervention/treatment
Experimental: FACAM
Intervention participants are assigned a support person (health nurse or a family therapist) who will offer support to the family until the child starts school at age 6. Intensity is up to 37 hours the first year followed by up to 10 hours of support each of the following years. The support person will offer individualized support to the family depending on the needs of the family. The support person will attend midwife consultations and help the pregnant woman to attend consultations with e.g. GP, midwife, or social worker. All intervention participants will also receive either an individual or group-based (COS-P)attachment based intervention during pregnancy and the first months of the child's life.
Behavioral: FACAM
Support person

Behavioral: COS-P
Attachment based therapy

Active Comparator: Care as Usual
Families in the control group receive the usual care that is offered to families in the target group. This includes consultations with e.g. a midwife, social worker, medical doctor, and health visitor. If needed, CAU families can receive e.g. extra home visits or family therapy.
Behavioral: Care as Usual
Usual care




Primary Outcome Measures :
  1. Maternal sensitivity [ Time Frame: at child age 12 months ]
    Maternal sensitivity measured by the CIB (Coding Interactive Behavior)


Secondary Outcome Measures :
  1. Maternal Sensitivity [ Time Frame: at child age 3 months ]
    Maternal sensitivity measured by the CIB (Coding Interactive Behavior)

  2. Coding interactive bahavior (CIB) [ Time Frame: child age 3 and 12 months ]
    Parent child relationship Subscales: Intrusiveness, Limit setting, Involvement, Withdrawal, Reciprocity, Negative states

  3. Ages and Stages Questionnaire-Social Emotional 2 (ASQ:SE-2) [ Time Frame: child age 3 and 12 months ]
    Child social-emotional Development Total score range 0-150 ( 3 months 15 items), 0-260 (12 months 26 items). Low score is better.

  4. Edinburgh Postnatal depression Scale (EPDS) [ Time Frame: child age 3 and 12 months ]
    Depression Total score range 0-30. Low score is better

  5. Warwick-Edinburgh Mental Well-being Scale [ Time Frame: child age 3 and 12 months ]
    Maternal mental Health 7 items. A total score i calculated by summing the 7 items and converting the raw score according to a published conversion table. Raw score range 7- 35. Converted score range 7-35. High is better outcome.

  6. Prenatal Parental reflective functioning questionnaire (P-PRFQ) [ Time Frame: Baseline ]

    Parental reflective functioning for pregnant women. Total score range 14-98. Higher score is better. Three subscales:

    Opacity of mental states (4 items), reflecting on the fetus-baby (3 items) and Dynamic of mental states (5 items)


  7. Parental reflective functioning questionnaire (PRFQ-1) [ Time Frame: child age 12 months ]
    Parental reflective functioning Three subscales score range 6-42: Pre-Mentalizing Modes (PRFQ-PM) 6 items. low score is better. Certainty about Mental States (PRFQ-CMS) 6 items high score is better. Interest and curiosity in mental states PRFQ-IC 6 items high score is better.

  8. Parental Stress Scale (PSS) [ Time Frame: Cild age 3 and 12 months ]
    Parental stress Total score range 18-90 low score is better

  9. Ages and Stages Questionnaire 3 (ASQ:3) [ Time Frame: child age 3 months ]
    Child development

  10. Activities with child [ Time Frame: child age 12 months ]
    Singing and reading Total score range 0-70. High score is better.

  11. Being a Mother (BAM-13) [ Time Frame: child age 3 and 12 months ]
    Maternal confidence. Total score range 0-39. Low score is better

  12. Hospital Anxiety and Depression Scale (HADS) [ Time Frame: Baseline, 3 and 12 months ]
    Two subscales Anxiety (range 0-21 low score is better) and depression (range 0-21 low score is better)

  13. Experiences in Close Relationship Scale-Short Form (ECR-S) [ Time Frame: Baseline ]
    Two subscales Anxiety (range 1-42 low score is better) and Avoidance (range 1-42 low score is better)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   15 Years and older   (Child, Adult, Older Adult)
Sexes Eligible for Study:   Female
Gender Based Eligibility:   Yes
Gender Eligibility Description:   Participants must be pregnant women
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Pregnant women admitted to the Familieambulatorium, and living in Odense municipality
  • Antenatal care group 3 or 4 according to the Danish health authorities' recommendations

Exclusion Criteria:

  • Life-threatening illness in parent or child
  • Not able to fill out questionnaires in Danish or English
  • Child in out of home care after birth
  • Pregnancy with twins
  • Previous participation in the FACAM project

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03659721


Locations
Layout table for location information
Denmark
VIVE - The Danish Centre of Applied Social Science
Copenhagen, Denmark, 1052
Odense University Hospital
Odense, Denmark, 5000
Sponsors and Collaborators
VIVE - The Danish Center for Social Science Research
Odense University Hospital
Syddansk Universitet
Odense Patient Data Explorative Network
Odense Kommune
Investigators
Layout table for investigator information
Principal Investigator: Maiken Pontoppidan, PhD VIVE
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: VIVE - The Danish Center for Social Science Research
ClinicalTrials.gov Identifier: NCT03659721    
Other Study ID Numbers: VIVE 100750-751
First Posted: September 6, 2018    Key Record Dates
Last Update Posted: January 25, 2022
Last Verified: January 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided
Plan Description: Study protocol and analysis plan will be available

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by VIVE - The Danish Center for Social Science Research:
Pregnant
Infant
Parent
Family
Mother
Support